申请人:——
公开号:US20040048878A1
公开(公告)日:2004-03-11
Certain thienopyrrolyl and furanopyrrolyl compounds are disclosed as useful to treat or prevent disorders and conditions mediated by the histamine H
4
receptor, including allergic rhinitis.
某些噻
吡咯基和呋咯咯基化合物被披露为治疗或预防由
组胺H4受体介导的疾病和症状,包括过敏性鼻炎。